SOUTH JORDAN, Utah, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive six-month findings from the single-arm AVG cohort of its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial. The data were presented at the 51st annual VEITHsymposium during the Novel Technologies in Hemodialysis Access session. An AVG is a synthetic tube that is used for long-term access to blood vessels for patients undergoing hemodia ...

STOCKHOLM, Nov. 21, 2024 /PRNewswire/ -- Eco Wave Power Global AB (publ) (Nasdaq: WAVE) ("Eco Wave Power" or the "Company"), a leading, publicly traded onshore wave energy technology company, is pleased to report its financial results as of and for the nine months ended September 30, 2024, and provide a corporate update.Management CommentaryOperationsIn the first nine months of 2024, Eco Wave Power achieved several significant milestones, demonstrating our commitment to growth and resilience. We continued t ...

LOS ANGELES, Nov. 18, 2024 /PRNewswire/ -- Eco Wave Power Global AB (NASDAQ: WAVE) ("Eco Wave Power" or the "Company"), a leading provider of onshore wave energy technology, is pleased to announce it has received the final Nationwide Permit (NWP) from the U.S. Army Corps of Engineers for its groundbreaking wave energy project at AltaSea's premises at the Port of Los Angeles.This milestone marks a significant step forward in the development of Eco Wave Power's pioneering wave energy project, which is set to ...

Core Viewpoint - Eco Wave Power has signed an agreement for the sale of its first wave energy generation unit to I-Ke International Ocean Energy Co, marking a significant step in the deployment of wave energy technology in Taiwan [1][3]. Group 1: Project Details - The project involves a 100KW pilot wave energy power station, with I-Ke providing full financing and purchasing a turnkey conversion unit from Eco Wave Power [3]. - The first stage of the project aims to develop a 20 MW wave energy power station, starting with the 100KW pilot and expanding to a total targeted installed capacity of 400 MW [4]. - I-Ke has identified 83 potential sites along the Taiwanese coastline for future commercial implementation of Eco Wave Power's technology [5][11]. Group 2: Company Background - Eco Wave Power is a publicly traded company specializing in onshore wave energy technology, with a mission to combat climate change by enabling commercial power production from ocean waves [12]. - The company has a project pipeline totaling 404.7 MW and has received funding from various European entities, including the European Union Regional Development Fund [14]. - I-Ke International Ocean Energy, a subsidiary of Lian Tat Company, focuses on developing wave power projects in Taiwan and aims to promote clean energy [10][11]. Group 3: Leadership and Partnerships - Inna Braverman, CEO of Eco Wave Power, expressed excitement about the project and acknowledged the support from local partners and the Taiwanese government [5]. - The project has garnered interest from key figures in Taiwan's energy sector, including Mr. Yu Zheng Wei and Mrs. Wang Mei Hua, indicating strong local support for the initiative [6]. - The collaboration between Eco Wave Power and I-Ke is seen as a strategic move to position Taiwan as a hub for wave energy expansion in the Asia-Pacific region [4].

The Project is Expected to Commence with a Landmark 100KW Pilot Project, and Gradually Expand to 20MW, Followed by an Ambitious Target of 400MW of Commercial Capacity on the Taiwanese Coastline. TEL AVIV, Israel, Oct. 7, 2024 /PRNewswire/ -- Eco Wave Power Global AB (publ) (Nasdaq: WAVE) ("Eco Wave Power" or the "Company"), a leading, publicly traded onshore wave energy technology company announced today that it signed an agreement for the sale of the first wave energy generation unit with I-Ke Internationa ...

SOUTH JORDAN, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive 6-month findings from the randomized arteriovenous (AV) fistula arm of its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial. The data were shown at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) during a FIRST@CIRSE presentation. WRAPSODY is a cell-impermeable endoprosthesis which is intended to extend l ...

Exhibit 99.1 Eco Wave Power Global AB (publ) Condensed consolidated financial statements As of June 30, 2024 Unaudited Index | --- | --- | |--------------------------------------------------------------------|-------| | | Page | | CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | 3 | | CONDENSED CONSOLIDATED STATEMENTS OF LOSS | 4 | | CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS | 5 | | CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY | 6 | | CONDENSED CONSOLIDATED STATEMENTS OF CAS ...

PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today its selection as a board member of the newly established Waveform Architecture for Virtualized Ecosystems (WAVE) Consortium. Gilat joins a distinguished group of board members committed to driving innovation in satellite communication networks through agile, scalable, and cost-effective infrastructure. Estab ...

Core Viewpoint - Eco Wave Power Global AB has received authorization from the Swedish Financial Supervisory Authority to repurchase up to 10 percent of its American Depositary Shares, following approval from shareholders at the 2024 Annual General Meeting [1][2][5]. Group 1: Repurchase Authorization - The Swedish Financial Supervisory Authority (SFSA) has determined that American Depositary Shares (ADS) are not equivalent to shares under Swedish law, allowing the company to proceed with the buyback [1]. - The repurchase program was approved by shareholders at the 2024 Annual General Meeting, granting the board the authority to buy back ADSs under specific conditions [2][3]. - The maximum number of ADS that can be repurchased is limited to 10 percent of the total shares, and purchases must occur on regulated markets at prices within the highest purchase and lowest selling price range [3]. Group 2: Execution and Management - The company will enter into agreements with a bank to facilitate the buyback process, which may include open market purchases or privately negotiated transactions [2][5]. - The timing and amount of repurchases will be determined by the company's management based on various market and economic conditions [5]. Group 3: Company Overview - Eco Wave Power is a leading onshore wave energy company that has developed patented technology for converting ocean waves into green electricity, contributing to climate change mitigation [6]. - The company operates a grid-connected wave energy project in Israel, recognized as pioneering technology, and is set to begin additional projects in Los Angeles and Portugal, with a total project pipeline of 404.7 MW [7][8].

Core Insights - Merit Medical Systems, Inc. is set to release findings from the WAVE study, which evaluates the safety and efficacy of the WRAPSODY Cell-Impermeable Endoprosthesis for treating stenosis in the venous outflow circuit [1][6] Study Details - The WAVE study enrolled 245 patients with stenosis in arteriovenous fistula (AVF) and 113 patients with stenosis in arteriovenous graft (AVG) [2] - Patients with AVF were randomized 1:1 to receive either WRAPSODY or standard care with percutaneous transluminal angioplasty (PTA) [2] - The study will follow patients for 24 months, with six-month safety and efficacy findings to be presented at various congresses this year [2] Presentation Schedule - The first results will focus on the AVF cohort and will be presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) on September 14 [3] - Specific results at six months will include target lesion primary patency, access circuit primary patency, and safety events [3] - A Merit-sponsored symposium will follow the presentation on September 16, featuring discussions on hemodialysis evidence and clinical strategies [4] Additional Findings - Core laboratory findings supporting the cell-impermeable design of WRAPSODY will be presented at the Controversies in Dialysis Access (CiDA) Symposium on October 5 [5] - The findings from the WAVE study are expected to support the Premarket Approval (PMA) application to the FDA for WRAPSODY, which is currently under an Investigational Device Exemption (IDE) [6] Company Background - Merit Medical Systems, Inc. was founded in 1987 and specializes in developing, manufacturing, and distributing proprietary disposable medical devices for interventional, diagnostic, and therapeutic procedures [7] - The company employs approximately 7,000 people worldwide and serves client hospitals globally with a dedicated sales force and clinical support team [7]